HoyleCohen’s AstraZeneca AZN Stock Holding History

HoyleCohen’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$224K	Buy	+1,438	New	+$216K	0.02%	257

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

HoyleCohen's AZN Position: Q2 2024 in Review

HoyleCohen opened a new position in AstraZeneca (AZN) in Q2 2024: 1,438 shares worth $224K. The stake represents 0.02% of the portfolio and ranks #257 among its holdings.

1,211 funds tracked by Wall St. Rank hold AZN as of Q2 2024.

HoyleCohen held 1,438 shares of AstraZeneca worth $224K as of Q2 2024.
AstraZeneca was a new HoyleCohen position in Q2 2024.
AstraZeneca made up 0.02% of HoyleCohen's portfolio in Q2 2024, its #257 holding.
1,211 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2024.

Based on HoyleCohen's 13F filing for Q2 2024, filed 19 Jul 2024.